Kestra Advisory Services, LLC

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1830819 AUSTIN, TX

Position in MDGL

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$724,882

+$11,916 QoQ

Shares Held

1,350

-0.9% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#221

of 411 holders

Holding Since

Dec 2022

15 quarters on record

Healthcare · as of Jun 30, 2026

Kestra Advisory Services, LLC holds $29,012,263 across 51 Biotechnology names. MDGL ranks #14 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	15,732	$7,814,556
2	REGN	Regeneron Pharmaceuticals, Inc.	2,893	$1,803,901
3	RPRX	Royalty Pharma plc	27,331	$1,532,449
4	CPRX	Catalyst Pharmaceuticals, Inc.	39,421	$1,239,002
5	VKTX	Viking Therapeutics, Inc.	27,091	$1,056,819
6	IBRX	ImmunityBio, Inc.	110,630	$968,565
7	CORT	Corcept Therapeutics Inc	10,914	$948,972
8	CRSP	CRISPR Therapeutics AG	17,292	$943,105

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$724,882	1,350	-0.9%	Shares	Sole	2026-07-28
2026-03-31	$712,966	1,362	-13.8%	Shares	Sole	2026-04-30
2025-12-31	$920,097	1,580	+0.8%	Shares	Sole	2026-02-13
2025-09-30	$718,720	1,567	-5.9%	Shares	Sole	2025-11-14
2025-06-30	$503,895	1,665	-2.4%	Shares	Sole	2025-08-15
2025-03-31	$565,078	1,706	+0.1%	Shares	Sole	2025-05-14
2024-12-31	$526,111	1,705	-34.8%	Shares	Sole	2025-02-10
2024-09-30	$554,743	2,614	+5.9%	Shares	Sole	2024-11-13
2024-06-30	$691,715	2,469	-4.5%	Shares	Sole	2024-08-14
2024-03-31	$690,031	2,584	-28.3%	Shares	Sole	2024-05-15
2023-12-31	$833,893	3,604	-0.1%	Shares	Sole	2024-02-14
2023-09-30	$526,620	3,606	+0.7%	Shares	Sole	2023-11-13
2023-06-30	$827,211	3,581	+39.9%	Shares	Sole	2023-08-11
2023-03-31	$620,185	2,560	+4.2%	Shares	Sole	2023-05-12
2022-12-31	$712,854	2,456	—	Shares	Sole	2023-01-31
No filing history on record for this holder in this stock.